ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33189-5mg |
|
1116743-46-4 |
SAR125844
|
0 | C25H23FN8O2S2 | |
GC33189-10mM(1mLinDMSO) |
|
1116743-46-4 |
SAR125844
|
0 | C25H23FN8O2S2 | |
GC33188-5mg |
|
446022-33-9 |
Pelitrexol (AG 2037)
|
0 | C20H25N5O6S | |
GC33188-10mg |
|
446022-33-9 |
Pelitrexol (AG 2037)
|
0 | C20H25N5O6S | |
GC33188-100mg |
|
446022-33-9 |
Pelitrexol (AG 2037)
|
0 | C20H25N5O6S | |
GC33188-50mg |
|
446022-33-9 |
Pelitrexol (AG 2037)
|
0 | C20H25N5O6S | |
GC33187-10mg |
|
2089148-72-9 |
A-395 (A395)
|
0 | C26H35FN4O2S | |
GC33187-5mg |
|
2089148-72-9 |
A-395 (A395)
|
0 | C26H35FN4O2S | |
GC33186-100mg |
|
2244904-70-7 |
BAY-293
|
0 | C25H28N4O2S | |
GC33186-50mg |
|
2244904-70-7 |
BAY-293
|
0 | C25H28N4O2S | |
GC33186-10mg |
|
2244904-70-7 |
BAY-293
|
0 | C25H28N4O2S | |
GC33186-5mg |
|
2244904-70-7 |
BAY-293
|
0 | C25H28N4O2S | |
GC33185-100mg |
|
849675-87-2 |
Encequidar mesylate (HM30181 (mesylate))
|
0 | C39H40N6O10S | |
GC33185-50mg |
|
849675-87-2 |
Encequidar mesylate (HM30181 (mesylate))
|
0 | C39H40N6O10S | |
GC33185-10mg |
|
849675-87-2 |
Encequidar mesylate (HM30181 (mesylate))
|
0 | C39H40N6O10S | |
GC33185-5mg |
|
849675-87-2 |
Encequidar mesylate (HM30181 (mesylate))
|
0 | C39H40N6O10S | |
GC33185-10mM(1mLinDMSO) |
|
849675-87-2 |
Encequidar mesylate (HM30181 (mesylate))
|
0 | C39H40N6O10S | |
GC33183-10mg |
|
2079885-05-3 |
L-45 (L-Moses)
|
0 | C21H24N6 | |
GC33183-5mg |
|
2079885-05-3 |
L-45 (L-Moses)
|
0 | C21H24N6 | |
GC33181-100mg |
|
1351927-00-8 |
T338C Src-IN-2
|
0 | C17H18FN5O | |